BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6613977)

  • 1. Sodium-lithium countertransport in erythrocytes of hypertension prone families in Utah.
    Williams RR; Hunt SC; Kuida H; Smith JB; Ash KO
    Am J Epidemiol; 1983 Sep; 118(3):338-44. PubMed ID: 6613977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-lithium countertransport in ambulatory hypertensive and normotensive patients.
    Turner ST; Boerwinkle E; Johnson M; Richelson E; Sing CF
    Hypertension; 1987 Jan; 9(1):24-34. PubMed ID: 2432010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of sodium-lithium countertransport and hypertension in Utah.
    Hunt SC; Stephenson SH; Hopkins PN; Hasstedt SJ; Williams RR
    Hypertension; 1991 Jan; 17(1):1-7. PubMed ID: 1986977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential hypertension: sodium-lithium countertransport in erythrocytes from patients and from children having one hypertensive parent.
    Ibsen KK; Jensen HA; Wieth JO; Funder J
    Hypertension; 1982; 4(5):703-9. PubMed ID: 7106937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell lithium-sodium countertransport and sodium-potassium cotransport in patients with essential hypertension.
    Adragna NC; Canessa ML; Solomon H; Slater E; Tosteson DC
    Hypertension; 1982; 4(6):795-804. PubMed ID: 7141606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity.
    Carr SJ; Sikand K; Moore D; Norman RI
    J Hypertens; 1995 Jan; 13(1):139-46. PubMed ID: 7759844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-lithium countertransport in erythrocytes of children and adolescents with hypertension.
    Norling LL; Goldring D; Hernandez A; Robson AM; Landt M
    Dev Pharmacol Ther; 1986; 9(4):231-40. PubMed ID: 3757730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased erythrocyte lithium--sodium countertransport in essential hypertension: its relationship to family history of hypertension.
    Canali M; Borghi L; Sani E; Curti A; Montanari A; Novarini A; Borghetti A
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():13s-15s. PubMed ID: 7318313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension.
    Weder AB
    N Engl J Med; 1986 Jan; 314(4):198-201. PubMed ID: 3941708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological studies of sodium transport and hypertension.
    McDonald A; Trevisan M; Cooper R; Stamler R; Gosch F; Ostrow D; Stamler J
    Hypertension; 1987 Nov; 10(5 Pt 2):I42-7. PubMed ID: 2824365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of lithium-potassium cotransport and the passive lithium leak to hypertension in Utah subjects.
    Hunt SC; Williams RR; Smith JB; Ash KO; Kuida H
    Clin Exp Hypertens A; 1985; 7(10):1409-26. PubMed ID: 4075541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na-Li countertransport kinetics in the relatives of hypertensive patients with abnormal Na-Li countertransport activity.
    Rutherford PA; Thomas TH; Wilkinson R
    Biochem Mol Med; 1997 Oct; 62(1):106-12. PubMed ID: 9367806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension.
    Nosadini R; Semplicini A; Fioretto P; Lusiani L; Trevisan R; Donadon V; Zanette G; Nicolosi GL; Dall'Aglio V; Zanuttini D
    Hypertension; 1991 Aug; 18(2):191-8. PubMed ID: 1885227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-lithium countertransport and hypertension in Rochester, Minnesota.
    Turner ST; Michels VV
    Hypertension; 1991 Aug; 18(2):183-90. PubMed ID: 1885226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of sodium-lithium countertransport in 10 hypertension-prone kindreds.
    Dadone MM; Hasstedt SJ; Hunt SC; Smith JB; Ash KO; Williams RR
    Am J Med Genet; 1984 Mar; 17(3):565-77. PubMed ID: 6585142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-lithium countertransport activity in healthy, dyslipidemic, and hypertensive individuals.
    Savopoulos CG; Hatzitolios AI; Katsiki NA; Baltatzi M; Kosmidou M; Raikos N; Mikhailidis DP; Ziakas AG; Kaiafa G; Tsesmeli N
    Angiology; 2008 Dec-2009 Jan; 59(6):727-35. PubMed ID: 18840623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell lithium-sodium countertransport in non-modulating essential hypertension.
    Redgrave J; Canessa M; Gleason R; Hollenberg NK; Williams GH
    Hypertension; 1989 Jun; 13(6 Pt 2):721-6. PubMed ID: 2544520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
    Siebers RW; Maling TJ
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three red cell sodium transport systems in hypertensive and normotensive Utah adults.
    Smith JB; Ash KO; Hunt SC; Hentschel WM; Sprowell W; Dadone MM; Williams RR
    Hypertension; 1984; 6(2 Pt 1):159-66. PubMed ID: 6327514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in Utah.
    Hunt SC; Williams RR; Ash KO
    Cardiovasc Drugs Ther; 1990 Mar; 4 Suppl 2():357-62. PubMed ID: 2271398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.